Recommended in Urology

  • Clinical Essentials from J Urol
  • 1 comment

Enzalutamide benefits patients with mCRPC with low PSA levels

Post hoc analysis of PREVAIL study.

Read more
  • Univadis
  • 1 comment

ASCO 2017 - Metastatic castration-resistant prostate cancer: indoximod after sipuleucel-T boosts PFSl in phase 2 trial

Read more
  • Univadis
  • 1 comment

ASCO 2017 - Urothelial cancer: pembrolizumab tops 2nd-line chemotherapy

Read more
  • Univadis
  • 1 comment

ASCO 2017 - High-intensity ctDNA assay promising in metastatic breast, lung, and prostate cancers

Read more
  • Univadis
  • 1 comment

ASCO 2017 - Newly diagnosed high-risk metastatic prostate cancer: the good news is abiraterone

Read more
  • Univadis
  • no comment

ASCO 2017 - High-risk prostate cancer: adding abiraterone to long-term ADT lowers mortality risk by 37%

Read more
  • Univadis
  • 1 comment

ASCO 2017 - Testicular cancer: hypogonadism after platinum-based chemo can lead to cardiovascular trouble

Read more
  • Clinical Essentials from Radiology
  • 1 comment

Microlithiasis strongly linked to testicular tumor in boys

Read more
  • Clinical Essentials from JAMA Intern Med
  • 1 comment

Meta-analysis: is vasectomy linked to prostate cancer?

Read more

Professional Essentials

  • US Professional News
  • FULLTEXT

Ohio practices join to stay independent

Read more
  • US Professional News
  • FULLTEXT

Surprise ED bills linked to staffing companies

Read more
  • US Professional News
  • FULLTEXT

Patients like correcting physician notes

Read more
  • US Professional News
  • FULLTEXT

5 tips to avoid denials

Read more
  • US Professional News
  • FULLTEXT

New standardized form eases patient record requests

Read more
  • US Professional News
  • FULLTEXT

Time to understand ACI

Read more
View more

New in Urology

  • Clinical Essentials from Urol Oncol
  • 1 comment

Antihypertensive use higher after partial vs radical nephrectomy

Hemodynamic parameters were comparable to radical nephrectomy.

Read more
  • Clinical Essentials from Diabet Med
  • no comment

Men with diabetes should be screened for erectile dysfunction

Over half of men with diabetes worldwide have erectile dysfunction.

Read more
  • Clinical Essentials from J Urol
  • 1 comment

Prostate cancer: Gleason pattern 5 linked to worst outcomes

Study evaluated cancer outcomes in high-risk men.

Read more
  • Clinical Essentials from BMC Med
  • 1 comment

Tall, obese men at higher risk for advanced prostate cancer

Large study analyzed men from EPIC cohort.

Read more
  • Clinical Essentials from Clin J Am Soc Nephrol
  • 1 comment

Localized renal cancer: radical nephrectomy tied to worst renal outcomes

A meta-analysis shows better renal function after partial nephrectomy or thermal ablation.

Read more
  • Clinical Essentials from N Engl J Med
  • 1 comment

Early prostate cancer: watchful waiting best in the long run

20 y follow-up of prostatectomy vs observation.

Read more
  • Clinical Essentials from Prostate Cancer Prostatic Dis
  • 1 comment

PSA screening: low-income group lagging behind

Racial differences in PSA screening related to socioeconomic status

Read more
  • Clinical Essentials from Medicine (Baltimore)
  • 1 comment

Exercise benefits patients with prostate cancer receiving ADT

ADT-related adverse events affect QoL in patients.

Read more
Immuno-oncology Vitals for July 2017
  • Vitals
  • 1 comment

Immuno-oncology Vitals for July 2017

Checkpoint inhibitors in urological cancers | Post-progression nivolumab safe and effective in advanced melanoma | Erlotinib works best with others in NSCLC | No significant survival advantage with ofatumumab therapy in CLL.

Read more
  • Clinical Essentials from Br J Cancer
  • 1 comment

Bladder cancer: urine test predicts recurrence

TERT mutation is a reliable, sensitive, and dynamic marker.

Read more
  • Clinical Essentials from Eur Urol
  • 1 comment

Unfavorable-risk prostate cancer: LDRB boost tops EBRT dose escalation

Study shows survival advantage despite declining use.

Read more
  • Clinical Essentials from J Urol
  • 1 comment

Prostate cancer: 8th AJCC staging system improves patient stratification

Validation of major changes made in the 8th edition of the AJCC staging system.

Read more
  • Clinical Essentials from Prim Care Diabetes
  • 1 comment

Which diabetes patients are most at risk for developing genital fungal infections with SGLT2 inhibitors?

Women and those with prior infections are more vulnerable.

Read more
  • Clinical Essentials from Prostate
  • 1 comment

MCRPC: when to alter dosing of anticancer therapy

Evidence-based recommendations for optimizing outcomes with docetaxel, cabazitaxel, enzalutamide, and abiraterone acetate.

Read more